Patent classifications
A61K47/6949
SELF-ASSEMBLED NANO-STRUCTURED PARTICLE AND METHODS FOR PREPARING
Novel, nano-structured particles are formed by introducing a selected solid of interest into a structured fluid matrix formed by a dispersion of a small molecule host vessel components, such as a native or modified polysaccharide, cavitand, simple sugar, disaccharide, simple polyol or other similarly structured molecule known to be useful as a host vessel, in an acidic medium or other solvent, whereby the particle size of the introduced solid is reduced and or limited in the structured fluid matrix, by incorporation into or attachment to, the host vessel. The simple, one-batch mixing process results in stabilized colloidal dispersions of the nanoparticles of a variety of solids of varying scope and function and useful in a wide variety of applications, including without limitation ceramic materials, such as hexagonal boron nitride.
GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE
Methods of treating cancer are provided that include administering glycan-interacting antibodies. Included are anti-sialyl Tn antigen antibodies and related compositions and formulations suitable to achieve desirable bioactivity, bioavailability, and toxicity levels.
ALZHEIMER'S DISEASE TREATMENT AND METHODS
A nanoparticle composed of buckminsterfullerene bonded to glutamine, gamma amino butyric acid (GABA) and adenosine triphosphate is provided. This nanoparticle helps to regulate the energy metabolism, neural excitability, and signal transduction within the synapse and between the astrocytes and the neuronal networks of the human brain when these become dysfunctional. It is intended as a treatment for Alzheimer's disease, Lewy Body disease and other neuropathological diseases of the glutamine-glutamate-GABA cycle. Utility for remediating comorbid sexual dysfunction is promoted, as well as the antioxidant and protein oligomer disassembly properties. The adenosine triphosphate adduct provides a reversible inorganic phosphate energy storage and supply, the glutamine adduct provides a stable reservoir of this amino acid that is resistant to breakdown by reactive oxygen species, reactive nitrogen species, and astrocytes. The GABA and buckminsterfullerene functional groups are anti-oxidants to treat the most oxidatively stressed regions at neural structures.
COMPLEX OR SALT THEREOF, AND METHOD FOR PRODUCING THE SAME
The present invention provides a highly controlled complex comprising an antibody and ferritin particles. More specifically, the present invention provides the inventions of a complex or salt thereof comprising (A) one IgG antibody and (B) two human ferritin particles comprising one or more human ferritin H chains linked thereto; and methods for producing the same.
C60 HISTIDINE CARNOSINE FUMARATES AND USE
A nanoparticle composed of buckminsterfullerene bonded to histidine, carnosine, and ferrous or gallous divalent metal (M) fumarate to from a molecular composition of C60-HIS-CAR-M-FUM is provided. This composition when complexed with iron is used as a treatment for hyperuricemia and gout to normalize uric acid removal from the blood and treat progressive kidney dysfunction. This composition when complexed with gallium is used to block the uptake of iron in the treatment of cancers and tumors, and by acting as a proton shuttle, primarily through histidine and C60, to help inhibit glycolysis in the Warburg effect. The composition may be administered as an oral solid formulation or as a liquid formulation.
FUSION PROTEIN AND APPLICATIONS THEREOF
Provided are a fusion protein comprising an antibody binding area and an endocytic functional area, the encoding nucleic acid of the protein, an expression vector of same, a host cell thereof, and an immune effector cell expressing the fusion protein or the endocytic functional area or further expressing a chimeric antigen receptors. Also provided are an immunoconjugate comprising a cell-killing part and an antibody conjugate in a specifically-binding immune effector cell or an antibody of the endocytic functional area, a reagent kit and uses of the immunoconjugate, and a method for specifically removing, selecting, or enriching and detecting the immune effector cell.
DOSE RESPONSE, SURFACE MODIFIED NANOTUBES
Discrete, individualized carbon nanotubes having targeted, or selective, oxidation levels or content and a functionalized surface coating are claimed. Such carbon nanotubes can have little to no inner tube surface oxidation, or differing amounts and/or types of oxidation between the tubes' inner and outer surfaces. These new discrete carbon nanotubes are useful for delivery and controlled release of drugs, chemicals, compounds, small molecules, oligonucleotides, peptides, proteins, enzymes, macromolecular gene-editing assemblies, other biologics and combinations of thereof. The functionalized surface coating may be utilized to preferentially direct the nanotubes to particular tissues, organs or regions of the body for controlled delivery and or release of a payload molecule.
AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF
The present invention provides an artificial TRAP-cage comprising a selected number of TRAP rings which are held in place by cross-linkers, wherein the cross-linkers are selected for their specific characteristics whereby the cages are programmable to be opened or remain closed on demand, under specific conditions.
Starch-derived clathrate-forming compositions
Embodiments of the present disclosure relate to materials and methods for preparing a clathrate-forming composition comprising a plurality of linear glucomonomer chains of about 15 to about 100 D-glucopyranosyl residues linked by ?-1,4 linkages, wherein the linear glucomonomer chains are a product of partial amylolysis of a modified starch substrate and wherein the product is flowable at temperatures within a range of 4-20? C. at about 20% w/v solids content. The present disclosure further describes methods of using the clathrate-forming compositions to form molecular dispersions or clathrates with hydrophobic guest molecules, kits for use in these methods, and molecular dispersions or clathrates obtained from the materials.
Isolated nanosheet and production method thereof
The present invention provides isolated nanosheets each of which includes a plurality of pseudo-polyrotaxanes and which are easily isolated without adhering to each other. The present invention provides an isolated nanosheet including a plurality of pseudo-polyrotaxanes each having one or more first cyclic molecules and a linear molecule included in a cavity or cavities of the first cyclic molecules in a skewered manner, wherein the linear molecules include, as part thereof, first linear molecules each having an ionizable group that ionizes in water or an aqueous solution.